New four-year data show Roche’s ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing